Everyday Health (EVDY) Says Sales Execution Problems Affected Consumer Segment; Leerink Partners Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Everyday Health and Videology Partner to Launch TVRx, the Industry's Most Comprehensive Data-Driven Video Solution for Pharma Advertisers
November 10, 2015 4:01 PM ESTNEW YORK, Nov. 10, 2015 /PRNewswire/ --Â Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions, and Videology, a leading software provider for converged TV and video advertising, today announced the launch of TVRx, a solution for pharmaceutical and health-oriented marketers to target relevant health audiences across television and digital video. The innovative partnership combines Everyday Health's extensive audience... More
Everyday Health Reports Third Quarter 2015 Financial Results
November 10, 2015 4:01 PM ESTNEW YORK, Nov. 10, 2015 /PRNewswire/ --Â Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions, today announced financial results for the third quarter ended September 30, 2015.
For the third quarter:
Total revenue grew 28% year-over-year. Advertising and sponsorship revenue grew 31% year-over-year. Average revenue per top 30 strategic advertiser increased 43% year-over-year. Pharma revenue grew 36% year-over-year. Cash flow from operations grew 29% year-over-year."In... More

